Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola

Stock Information for Acer Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Acer Therapeutics Inc.

Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025
Cibus Announces the Election of Craig Wichner to Board of Directors
Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call
Cibus and AgVay? Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene Editing
Cibus Announces the Election of Kimberly A. Box to Board of Directors
Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025
Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus' Herbicide Tolerance Trait

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.